Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1254 (LINC01254)
- Target
- LINC01254
- Molecular classification
- Long non-coding RNA (lncRNA), Intergenic lncRNA (lincRNA)
01
Overview
Long intergenic non-protein coding RNA 1254 (LINC01254) is a long non-coding RNA transcript classified as a lincRNA, meaning it is located between protein-coding genes with no protein-coding potential[1][3][7]. The gene symbol is LINC01254, and its accessions in major databases include NCBI Gene: 101927350 and Ensembl: ENSG00000260913[3]. The precise biological function, disease association, and clinical relevance of LINC01254 remain uncharacterized. As with other lincRNAs, its potential functions—drawing from lincRNA biology overall—may include regulation of gene expression, epigenetic modification, transcriptional regulation, and modulation of nuclear architecture[5][7][9]. However, these are inferred roles rather than direct evidence for this specific RNA. At present, LINC01254 is not recognized as a validated therapeutic target, does not have known drug interactions, and is not used as a biomarker. Further research is needed to clarify its significance, if any, in human biology or pathology[1][3].
- Other names
- LINC01254Long intergenic non-protein coding RNA 1254
02
Mechanism of action
None. As LINC01254 is not a drug target, there are no known mechanisms of action for drugs targeting this RNA.
03
Biological functions
No direct functional annotations for LINC01254 are available in current databases or literatureRegulation of gene expressionEpigenetic modification (including histone methylation and chromatin remodeling)Transcriptional regulationModulation of nuclear architecture
04
Disease associations
No specific disease associations have been described for LINC01254 as of current evidencelincRNAs as a class are broadly implicated in various diseases, especially cancer, immune regulation, and other multifactorial conditions, but individual disease involvement for LINC01254 is unknown.
05
Safety considerations
None reported. As LINC01254 is not a drug target, no safety concerns have been associated with its modulation.
06
Interacting drugs
None. No drugs are currently documented to interact with LINC01254.
07
Biomarkers
None specifically reported for LINC01254. lncRNAs can sometimes serve as biomarkers in oncology and other fields, but no evidence exists for this molecule.
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 1254 (LINC01254).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1254 (LINC01254).